CIVILICA We Respect the Science
Publisher of Iranian Journals and Conference Proceedings
Paper
title

Application of digital PCR to clinical diagnostics: The first option toward personalized medicine

Credit to Download: 0 | Page Numbers 1 | Abstract Views: 126
Year: 2016
COI code: IPMCMED01_144
Paper Language: English

How to Download This Paper

For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.

Authors Application of digital PCR to clinical diagnostics: The first option toward personalized medicine

  Fatemeh Mansouri - urmia university of medical sciences

Abstract:

The origins and principles of digital PCR as a new clinical diagnostics based on the ability of absolute quantitation to detect a single molecule of the target genes. This technology is used for detection of DNA, RNA, microRNA and other biomarkers with a limited number of targets and a range of small concentrations. The samples must be diluted and divided into a large number of aliquots so that some aliquots receive one molecule of the target gene. The number of positive aliquots, as performed on thermocycler reflects the abundance of the target genes in the sample and measure flourescence signal after each cycle of PCR. Positive samples have increased fluorescence against negative samples and quanta software measures the number of positive and negative samples per fluorescence. It provides absolute and extremely high resolution for target quantification without the need for a standard curve and makes the correct measurement of very few copies of a target. If the sample is sufficiently dilute, only a few of the aliquots will be positive and each of these positive aliquots can be assumed to have contained only a single target molecule. Digital PCR only detects specific targets DNA or RNA and cannot detect proteins or degraded DNA molecules and adjusted for multiple targets. Although this method is very expensive but is very suited for detection individual biomarkers in cancer with a limited number of targets molecules (DNA, RNA, miRNA) in all biofluid samples, Circulating tumor cells and tumor surrounded by normal cells. Moreover, digital PCR is a robust method for quantifying genome amplification, fetal DNA in maternal blood and copy number variation in formalin fixed paraffin embedded in tumors, cardiovascular disease and diabetes.

Keywords:

Clinical diagnostic, Digital PCR, Biomarker

Perma Link

https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_144.html
COI code: IPMCMED01_144

how to cite to this paper:

If you want to refer to this article in your research, you can easily use the following in the resources and references section:
Mansouri, Fatemeh, 2016, Application of digital PCR to clinical diagnostics: The first option toward personalized medicine, First Personal Medical Congress, تهران, دانشگاه علوم پزشكي ايران - پژوهشكده ملي مهندسي ژنتيك و زيست فناوري ايران، مركز همكاري هاي فناوري و نوآوري هاي رياست جمهوري, https://www.civilica.com/Paper-IPMCMED01-IPMCMED01_144.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (Mansouri, Fatemeh, 2016)
Second and more: (Mansouri, 2016)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)

Scientometrics

The University/Research Center Information:
Type: Medical University
Paper No.: 452
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.

Research Info Management

Export Citation info of this paper to research management softwares

New Related Papers

Iran Scientific Advertisment Netword

Share this paper

WHAT IS COI?

COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.